Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04311723 · ClinicalTrials.gov registry record · NA
Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04311723: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT04311723 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04311723, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This trial compares two different types of ventilation for the prevention of partial or complete collapsed lung (atelectasis) in patients undergoing bronchoscopy under general anesthesia. Ventilatory strategy to prevent atelectasis (VESPA) may work better than standard of care mechanical ventilation to reduce the intra-procedural development of atelectasis during bronchoscopy under general anesthesia.
Interventions
- PROCEDURE Bronchoscopy
- PROCEDURE Anesthesia Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-05-27 |
| Est. Completion | 2024-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04311723
The ClinicalTrials.gov registry entry for NCT04311723 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bronchoscopy is the first listed.
NCT04311723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04311723 about?
NCT04311723 is a clinical study titled "Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial". This trial compares two different types of ventilation for the prevention of partial or complete collapsed lung (atelectasis) in patients undergoing bronchoscopy under general anesthesia. Ventilatory strategy to prevent atelectasis (VESPA) may work better than standard of care mechanical ventilation...
What is the current status of trial NCT04311723?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2020-05-27. Estimated completion is 2024-03-21.
What interventions are being tested in trial NCT04311723?
The interventions under investigation include: Bronchoscopy (PROCEDURE), Anesthesia Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT04311723?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.